Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Midazolam × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urothelial Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumor 1 Skin Neoplasms 1 Rectal Neoplasms 1 Polyps 1 Patient Satisfaction 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diverticulosis, Colonic 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Brain Neoplasms 1 Brain Diseases 1 Anxiety Disorders 1 Advanced Cancer 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡